Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity

FEBS Letters

Volumn 585, Issue 23, 2011, Pages 3611-3618

  Chen, Xin ^a   Oppenheim, Joost J ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Effector T cell; Regulatory T cell; TNF; TNFR2

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; EFFECTOR CELL; HUMAN; LYMPHOCYTE FUNCTION; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH17 CELL; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNITY; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052680230     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.04.025     Document Type: Review

References (106)

1. B.B. Aggarwal Signalling pathways of the TNF superfamily: A double-edged sword Nat. Rev. Immunol. 3 2003 745 756 (Pubitemid 41070815)
2. P. Vassalli The pathophysiology of tumor necrosis factors Annu. Rev. Immunol. 10 1992 411 452
3. G. Sethi, B. Sung, and B.B. Aggarwal TNF: A master switch for inflammation to cancer Front Biosci. 13 2008 5094 5107 (Pubitemid 351599660)
4. M. Kriegler, C. Perez, K. DeFay, I. Albert, and S.D. Lu A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF Cell 53 1988 45 53
5. R.A. Black A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells Nature 385 1997 729 733 (Pubitemid 27098094)
6. P. Vandenabeele, W. Declercq, R. Beyaert, and W. Fiers Two tumour necrosis factor receptors: structure and function Trends Cell Biol. 5 1995 392 399
7. J.K. Pinckard, K.C. Sheehan, C.D. Arthur, and R.D. Schreiber Constitutive shedding of both p55 and p75 murine TNF receptors in vivo J. Immunol. 158 1997 3869 3873 (Pubitemid 127488746)
8. S. Xanthoulea, M. Pasparakis, S. Kousteni, C. Brakebusch, D. Wallach, J. Bauer, H. Lassmann, and G. Kollias Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases J. Exp. Med. 200 2004 367 376 (Pubitemid 39031255)
9. M. Grell The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor Cell 83 1995 793 802
10. G. Chen, and D.V. Goeddel TNF-R1 signaling: A beautiful pathway Science 296 2002 1634 1635 (Pubitemid 34579145)
11. H. Wajant, K. Pfizenmaier, and P. Scheurich Tumor necrosis factor signaling Cell Death Differ. 10 2003 45 65 (Pubitemid 36511832)
12. M. Grell, F.M. Becke, H. Wajant, D.N. Mannel, and P. Scheurich TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1 Eur. J. Immunol. 28 1998 257 263 (Pubitemid 28048296)
13. H.A. Arnett, J. Mason, M. Marino, K. Suzuki, G.K. Matsushima, and J.P. Ting TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination Nat. Neurosci. 4 2001 1116 1122 (Pubitemid 34116557)
14. A.P. Cope Regulation of autoimmunity by proinflammatory cytokines Curr. Opin. Immunol. 10 1998 669 676 (Pubitemid 28558582)
15. J. Clark, P. Vagenas, M. Panesar, and A.P. Cope What does tumour necrosis factor excess do to the immune system long term? Ann. Rheum. Dis. 64 Suppl. 4 2005 iv70 iv76
16. G. Kollias, and D. Kontoyiannis Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments Cytokine Growth Factor Rev. 13 2002 315 321
17. A.A. Kruglov, A. Kuchmiy, S.I. Grivennikov, A.V. Tumanov, D.V. Kuprash, and S.A. Nedospasov Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models Cytokine Growth Factor Rev. 19 2008 231 244
18. I.S. Grewal, K.D. Grewal, F.S. Wong, D.E. Picarella, C.A. Janeway Jr.; and R.A. Flavell Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells J. Exp. Med. 184 1996 1963 1974 (Pubitemid 26404486)
19. C.O. Jacob, S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1 Proc. Natl Acad. Sci. USA 87 1990 968 972
20. D. Kontoyiannis, and G. Kollias Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor Eur. J. Immunol. 30 2000 2038 2047 (Pubitemid 30456200)
21. G. Kollias, D. Kontoyiannis, E. Douni, and G. Kassiotis The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized 'anti-TNF' therapies Curr. Dir. Autoimmun. 5 2002 30 50
22. G. Kassiotis, and G. Kollias Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination J. Exp. Med. 193 2001 427 434 (Pubitemid 32524474)
23. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775 787 (Pubitemid 351707693)
24. A.M. Thornton, and E.M. Shevach Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific J. Immunol. 164 2000 183 190 (Pubitemid 30012989)
25. M. Karim, G. Feng, K.J. Wood, and A.R. Bushell CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystanDer regulation Blood 105 2005 4871 4877 (Pubitemid 40807316)
26. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J. Exp. Med. 188 1998 287 296 (Pubitemid 28357757)
27. C.A. Piccirillo, and E.M. Shevach Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells J. Immunol. 167 2001 1137 1140 (Pubitemid 32703105)
28. P. Trzonkowski, E. Szmit, J. Mysliwska, A. Dobyszuk, and A. Mysliwski CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction Clin. Immunol. 112 2004 258 267 (Pubitemid 39078701)
29. T. Azuma, T. Takahashi, A. Kunisato, T. Kitamura, and H. Hirai Human CD4+ CD25+ regulatory T cells suppress NKT cell functions Cancer Res. 63 2003 4516 4520 (Pubitemid 36951023)
30. L. Cederbom, H. Hall, and F. Ivars CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells Eur. J. Immunol. 30 2000 1538 1543 (Pubitemid 30342794)
31. Y. Fu, S. Yi, J. Wu, E. Jimenez, D. Simond, W.J. Hawthorne, and P.J. O'Connell In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+CD25+ regulatory T cells Transplantation 86 2008 865 874
32. S.J. Seo The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells Immunity 16 2002 535 546
33. M. Miyara, and S. Sakaguchi Natural regulatory T cells: mechanisms of suppression Trends Mol. Med. 13 2007 108 116 (Pubitemid 46341958)
34. N.A. Danke, D.M. Koelle, C. Yee, S. Beheray, and W.W. Kwok Autoreactive T cells in healthy individuals J. Immunol. 172 2004 5967 5972 (Pubitemid 38621196)
35. S.L. Reiner Development in motion: helper T cells at work Cell 129 2007 33 36 (Pubitemid 46507593)
36. V.C. Liu Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta J. Immunol. 178 2007 2883 2892 (Pubitemid 46333166)
37. C.T. Weaver, L.E. Harrington, P.R. Mangan, M. Gavrieli, and K.M. Murphy Th17: an effector CD4 T cell lineage with regulatory T cell ties Immunity 24 2006 677 688 (Pubitemid 43867371)
38. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
39. M. Veldhoen, R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells Immunity 24 2006 179 189 (Pubitemid 43214587)
40. L. Zhou TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function Nature 453 2008 236 240 (Pubitemid 351667978)
41. X.O. Yang Molecular antagonism and plasticity of regulatory and inflammatory T cell programs Immunity 29 2008 44 56
42. M. Lochner In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells J. Exp. Med. 205 2008 1381 1393 (Pubitemid 351831494)
43. K.S. Voo Identification of IL-17-producing FOXP3+ regulatory T cells in humans Proc. Natl Acad. Sci. USA 106 2009 4793 4798
44. J.M. Kim, J.P. Rasmussen, and A.Y. Rudensky Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice Nat. Immunol. 8 2007 191 197 (Pubitemid 46152650)
45. R.A. O'Connor, K.H. Malpass, and S.M. Anderton The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells J. Immunol. 179 2007 958 966
46. H.G. Evans, T. Suddason, I. Jackson, L.S. Taams, and G.M. Lord Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes Proc. Natl Acad. Sci. USA 104 2007 17034 17039 (Pubitemid 350210986)
47. J. Lohr, B. Knoechel, J.J. Wang, A.V. Villarino, and A.K. Abbas Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease J. Exp. Med. 203 2006 2785 2791 (Pubitemid 46026156)
48. M. Feldmann Development of anti-TNF therapy for rheumatoid arthritis Nat. Rev. Immunol. 2 2002 364 371 (Pubitemid 37328759)
49. X. Chen, J.J. Subleski, H. Kopf, O.M. Howard, D.N. Mannel, and J.J. Oppenheim Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells J. Immunol. 180 2008 6467 6471
50. X. Chen, R. Hamano, J.J. Subleski, A.A. Hurwitz, O.M. Howard, and J.J. Oppenheim Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells J. Immunol. 185 2010 174 182
51. J.G. Baseta, and O. Stutman TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset J. Immunol. 165 2000 5621 5630
52. M.P. Everson, J.H. Eldridge, and W.J. Koopman Synergism of interleukin 7 with the thymocyte growth factors interleukin 2, interleukin 6, and tumor necrosis factor alpha in the induction of thymocyte proliferation Cell. Immunol. 127 1990 470 482 (Pubitemid 20147803)
53. M.S. Krangel, H. Yssel, C. Brocklehurst, and H. Spits A distinct wave of human T cell receptor gamma/delta lymphocytes in the early fetal thymus: evidence for controlled gene rearrangement and cytokine production J. Exp. Med. 172 1990 847 859 (Pubitemid 20301231)
54. F. Annunziato Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes J. Exp. Med. 196 2002 379 387 (Pubitemid 34879113)
55. F.S. Kleijwegt, S. Laban, G. Duinkerken, A.M. Joosten, A. Zaldumbide, T. Nikolic, and B.O. Roep Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells J. Immunol. 185 2010 1412 1418
56. V. Ablamunits, B. Bisikirska, and K.C. Herold Acquisition of regulatory function by human CD8(+) T cells treated with anti-CD3 antibody requires TNF Eur. J. Immunol. 40 2010 2891 2901
57. G.J. Van Mierlo, H.U. Scherer, M. Hameetman, M.E. Morgan, R. Flierman, T.W. Huizinga, and R.E. Toes Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators J. Immunol. 180 2008 2747 2751
58. M. Nagar TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function J. Immunol. 184 2010 3570 3581
59. D. Mougiakakos, C.C. Johansson, R. Jitschin, M. Bottcher, and R. Kiessling Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress Blood 117 2011 857 861
60. R.G. Van Der Most, A.J. Currie, S. Mahendran, A. Prosser, A. Darabi, B.W. Robinson, A.K. Nowak, and R.A. Lake Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: A role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy Cancer Immunol. Immunother. 2008
61. G. Minigo Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria PLoS Pathog. 5 2009 e1000402
62. J.M. Van Amelsfort, K.M. Jacobs, J.W. Bijlsma, F.P. Lafeber, and L.S. Taams CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid Arthritis Rheum. 50 2004 2775 2785 (Pubitemid 39209514)
63. S. Yokota, T.D. Geppert, and P.E. Lipsky Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha J. Immunol. 140 1988 531 536
64. D. Banerjee, H.C. Liou, and R. Sen C-Rel-dependent priming of naive T cells by inflammatory cytokines Immunity 23 2005 445 458 (Pubitemid 41443445)
65. R.M. Aspalter, M.M. Eibl, and H.M. Wolf Regulation of TCR-mediated T cell activation by TNF-RII J. Leukoc. Biol. 74 2003 572 582 (Pubitemid 38040385)
66. E.Y. Kim, and H.S. Teh TNF type 2 receptor (p75) lowers the threshold of T cell activation J. Immunol. 167 2001 6812 6820 (Pubitemid 33144172)
67. E.Y. Kim, J.J. Priatel, S.J. Teh, and H.S. Teh TNF Receptor Type 2 (p75) Functions as a Costimulator for Antigen-Driven T Cell Responses In Vivo J. Immunol. 176 2006 1026 1035 (Pubitemid 43099703)
68. E.Y. Kim, H.H. Chi, R. Rajaiah, and K.D. Moudgil Exogenous tumour necrosis factor alpha induces suppression of autoimmune arthritis Arthritis Res. Ther. 10 2008 R38
69. I. Chatzidakis, G. Fousteri, D. Tsoukatou, G. Kollias, and C. Mamalaki An essential role for TNF in modulating thresholds for survival, activation, and tolerance of CD8+ T cells J. Immunol. 178 2007 6735 6745 (Pubitemid 46847397)
70. Y. Grinberg-Bleyer Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs J. Clin. Invest. 120 2010 4558 4568
71. X. Chen, M. Baumel, D.N. Mannel, O.M. Howard, and J.J. Oppenheim Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells J. Immunol. 179 2007 154 161 (Pubitemid 46986529)
72. A.P. Cope, M. Londei, N.R. Chu, S.B. Cohen, M.J. Elliott, F.M. Brennan, R.N. Maini, and M. Feldmann Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis J. Clin. Invest. 94 1994 749 760
73. A.P. Cope Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling J. Exp. Med. 185 1997 1573 1584 (Pubitemid 27203254)
74. P. Isomaki, M. Panesar, A. Annenkov, J.M. Clark, B.M. Foxwell, Y. Chernajovsky, and A.P. Cope Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface J. Immunol. 166 2001 5495 5507 (Pubitemid 32374171)
75. E. Bryl, A.N. Vallejo, C.M. Weyand, and J.J. Goronzy Down-regulation of CD28 expression by TNF-alpha J. Immunol. 167 2001 3231 3238
76. R.M. Aspalter, H.M. Wolf, and M.M. Eibl Chronic TNF-alpha exposure impairs TCR-signaling via TNF-RII but not TNF-RI Cell. Immunol. 237 2005 55 67 (Pubitemid 41821082)
77. X. Chen, and J.J. Oppenheim TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells Curr. Dir. Autoimmun. 11 2010 119 134
78. M. Karin, and A. Lin NF-kappaB at the crossroads of life and death Nat. Immunol. 3 2002 221 227
79. G.R. Hill, T. Teshima, V.I. Rebel, O.I. Krijanovski, K.R. Cooke, Y.S. Brinson, and J.L. Ferrara The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity J. Immunol. 164 2000 656 663 (Pubitemid 30043685)
80. H.P. Eugster, K. Frei, R. Bachmann, H. Bluethmann, H. Lassmann, and A. Fontana Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1 Eur. J. Immunol. 29 1999 626 632 (Pubitemid 29078524)
81. M. Evangelidou, V. Tseveleki, S.S. Vamvakas, and L. Probert TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses Immunol. Cell Biol. 88 2010 586 595
82. Y.C. Twu, M.R. Gold, and H.S. Teh TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells Eur. J. Immunol. 41 2011 335 344
83. L.D. Church TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx J. Leukoc. Biol. 78 2005 266 278 (Pubitemid 40979966)
84. M.W. Marino Characterization of tumor necrosis factor-deficient mice Proc. Natl Acad. Sci. USA 94 1997 8093 8098 (Pubitemid 27343782)
85. T. Bongartz, A.J. Sutton, M.J. Sweeting, I. Buchan, E.L. Matteson, and V. Montori Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2006 2275 2285 (Pubitemid 43736578)
86. Chatzidakis, I.; Mamalaki, C. T cells as sources and targets of TNF: implications for immunity and autoimmunity. Curr. Dir. Autoimmun. 11, 105-118.
87. X. Chen, O.M. Howard, and J.J. Oppenheim Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells J. Immunol. 178 2007 6123 6129 (Pubitemid 46717393)
88. T. Calzascia, M. Pellegrini, H. Hall, L. Sabbagh, N. Ono, A.R. Elford, T.W. Mak, and P.S. Ohashi TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice J. Clin. Invest. 117 2007 3833 3845 (Pubitemid 350224093)
89. H.L. Ma, L. Napierata, N. Stedman, S. Benoit, M. Collins, C. Nickerson-Nutter, and D.A. Young Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells Arthritis Rheum. 62 2010 430 440
90. C.A. Notley, J.J. Inglis, S. Alzabin, F.E. McCann, K.E. McNamee, and R.O. Williams Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells J. Exp. Med. 205 2008 2491 2497
91. Aerts, N.E.; De Knop, K.J.; Leysen, J.; Ebo, D.G.; Bridts, C.H.; Weyler, J.J.; Stevens, W.J.; De Clerck, L.S. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (Oxford) 49, 2264-2272.
92. A.M. Bilate, and J.J. Lafaille Can TNF-alpha boost regulatory T cells? J. Clin. Invest. 120 2010 4190 4192
93. G. Penna, A. Roncari, S. Amuchastegui, K.C. Daniel, E. Berti, M. Colonna, and L. Adorini Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1, 25-dihydroxyvitamin D3 Blood 106 2005 3490 3497 (Pubitemid 41609185)
94. W.W. Unger, S. Laban, F.S. Kleijwegt, A.R. Van Der Slik, and B.O. Roep Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1 Eur. J. Immunol. 39 2009 3147 3159
95. M.R. Walker, D.J. Kasprowicz, V.H. Gersuk, A. Benard, M. Van Landeghen, J.H. Buckner, and S.F. Ziegler Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells J. Clin. Invest. 112 2003 1437 1443 (Pubitemid 38057697)
96. D. Mougiakakos, C.C. Johansson, and R. Kiessling Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death Blood 113 2009 3542 3545
97. M.R. Ehrenstein, J.G. Evans, A. Singh, S. Moore, G. Warnes, D.A. Isenberg, and C. Mauri Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy J. Exp. Med. 200 2004 277 285 (Pubitemid 39031247)
98. C.R. Ruprecht, M. Gattorno, F. Ferlito, A. Gregorio, A. Martini, A. Lanzavecchia, and F. Sallusto Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia J. Exp. Med. 201 2005 1793 1803 (Pubitemid 41002898)
99. X. Valencia, G. Stephens, R. Goldbach-Mansky, M. Wilson, E.M. Shevach, and P.E. Lipsky TNF down-modulates the function of human CD4+CD25hi T regulatory cells Blood 108 2006 253 261 (Pubitemid 43990636)
100. E. Toubi, A. Kessel, Z. Mahmudov, K. Hallas, M. Rozenbaum, and I. Rosner Increased Spontaneous Apoptosis of CD4+CD25+ T Cells in Patients with Active Rheumatoid Arthritis Is Reduced by Infliximab Ann. N. Y. Acad. Sci. 1051 2005 506 514 (Pubitemid 41362778)
101. K. Monte, C. Wilson, and F.F. Shih Increased number and function of FoxP3 regulatory T cells during experimental arthritis Arthritis Rheum. 58 2008 3730 3741
102. S. Nadkarni, C. Mauri, and M.R. Ehrenstein Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta J. Exp. Med. 204 2007 33 39 (Pubitemid 46148753)
103. G.S. Deepe Jr.; and R.S. Gibbons TNF-alpha antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmosis J. Immunol. 180 2008 1088 1097
104. A.M. Thornton, E.E. Donovan, C.A. Piccirillo, and E.M. Shevach Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function J. Immunol. 172 2004 6519 6523 (Pubitemid 38669083)
105. T. Nomura Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice J. Control. Release 149 2011 8 14
106. X. Chen, J.J. Subleski, R. Hamano, O.M. Howard, R.H. Wiltrout, and J.J. Oppenheim Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood Eur. J. Immunol. 40 2010 1099 1106